These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 31785006

  • 1. Serum IgA Fc effector functions in infectious disease and cancer.
    Davis SK, Selva KJ, Kent SJ, Chung AW.
    Immunol Cell Biol; 2020 Apr; 98(4):276-286. PubMed ID: 31785006
    [Abstract] [Full Text] [Related]

  • 2. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA, van Egmond M.
    Immunol Lett; 2004 Mar 29; 92(1-2):23-31. PubMed ID: 15081523
    [Abstract] [Full Text] [Related]

  • 3. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A, van Egmond M.
    Front Immunol; 2019 Mar 29; 10():553. PubMed ID: 30984170
    [Abstract] [Full Text] [Related]

  • 4. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
    Brandsma AM, Bondza S, Evers M, Koutstaal R, Nederend M, Jansen JHM, Rösner T, Valerius T, Leusen JHW, Ten Broeke T.
    Front Immunol; 2019 Mar 29; 10():704. PubMed ID: 31031746
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH, van Egmond M.
    Eur J Clin Invest; 2017 Feb 29; 47(2):184-192. PubMed ID: 28024097
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr 29; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 7. IgA and the IgA Fc receptor.
    van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG.
    Trends Immunol; 2001 Apr 29; 22(4):205-11. PubMed ID: 11274926
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P.
    MAbs; 2015 Apr 29; 7(4):743-51. PubMed ID: 25970007
    [Abstract] [Full Text] [Related]

  • 9. The human IgA-Fc alpha receptor interaction and its blockade by streptococcal IgA-binding proteins.
    Woof JM.
    Biochem Soc Trans; 2002 Aug 29; 30(4):491-4. PubMed ID: 12196121
    [Abstract] [Full Text] [Related]

  • 10. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov 29; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 11. Structure and function of human IgA Fc receptors (Fc alpha R).
    Morton HC, van Egmond M, van de Winkel JG.
    Crit Rev Immunol; 1996 Nov 29; 16(4):423-40. PubMed ID: 8954257
    [Abstract] [Full Text] [Related]

  • 12. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
    van der Pol W, Vidarsson G, Vilé HA, van de Winkel JG, Rodriguez ME.
    J Infect Dis; 2000 Oct 29; 182(4):1139-45. PubMed ID: 10979910
    [Abstract] [Full Text] [Related]

  • 13. Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees and rhesus macaques.
    Morton HC, Pleass RJ, Storset AK, Brandtzaeg P, Woof JM.
    Immunology; 2005 May 29; 115(1):74-84. PubMed ID: 15819699
    [Abstract] [Full Text] [Related]

  • 14. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M, Khamassi M, Xu L, Tudor D, Bomsel M.
    Front Immunol; 2018 May 29; 9():244. PubMed ID: 29651286
    [Abstract] [Full Text] [Related]

  • 15. Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
    Woof JM.
    Biochem Soc Trans; 2016 Dec 15; 44(6):1651-1658. PubMed ID: 27913674
    [Abstract] [Full Text] [Related]

  • 16. Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA.
    Cottignies-Calamarte A, Tudor D, Bomsel M.
    Front Immunol; 2023 Dec 15; 14():1037033. PubMed ID: 36817447
    [Abstract] [Full Text] [Related]

  • 17. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB, Ballister ER, Bjorkman PJ.
    Nature; 2003 Jun 05; 423(6940):614-20. PubMed ID: 12768205
    [Abstract] [Full Text] [Related]

  • 18. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
    Huls G, Heijnen IA, Cuomo E, van der Linden J, Boel E, van de Winkel JG, Logtenberg T.
    Cancer Res; 1999 Nov 15; 59(22):5778-84. PubMed ID: 10582699
    [Abstract] [Full Text] [Related]

  • 19. Nonhuman primate IgA: genetic heterogeneity and interactions with CD89.
    Rogers KA, Jayashankar L, Scinicariello F, Attanasio R.
    J Immunol; 2008 Apr 01; 180(7):4816-24. PubMed ID: 18354205
    [Abstract] [Full Text] [Related]

  • 20. Molecular characteristics of IgA and IgM Fc binding to the Fcalpha/muR.
    Cho Y, Usui K, Honda S, Tahara-Hanaoka S, Shibuya K, Shibuya A.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):474-8. PubMed ID: 16681999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.